Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Luigi Pasini"'
Autor:
Elisabetta Petracci, Luigi Pasini, Milena Urbini, Enriqueta Felip, Franco Stella, Fabio Davoli, Maurizio Salvi, Michele Beau-Faller, Michela Tebaldi, Irene Azzali, Matteo Canale, Piergiorgio Solli, Giulia Lai, Ramon Amat, Caterina Carbonell, Pierre-Emmanuel Falcoz, Alex Martinez-Marti, Erwan Pencreach, Angelo Delmonte, Lucio Crinò, Paola Ulivi
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-14 (2024)
Abstract Background Factors to accurately stratify patients with early-stage non-small cell lung cancer (NSCLC) in different prognostic groups are still needed. This study aims to investigate 1) the prognostic potential of circulating cell-free (CF)
Externí odkaz:
https://doaj.org/article/a21e55c42e3a48e29c60494710709dba
Autor:
Alberto Verlicchi, Matteo Canale, Elisa Chiadini, Paola Cravero, Milena Urbini, Kalliopi Andrikou, Luigi Pasini, Michele Flospergher, Marco Angelo Burgio, Lucio Crinò, Paola Ulivi, Angelo Delmonte
Publikováno v:
Life, Vol 13, Iss 9, p 1915 (2023)
Lung cancer (LC) is the deadliest malignancy worldwide. In an operable stage I–III patient setting, the detection of minimal residual disease (MRD) after curative treatment could identify patients at higher risk of relapse. In this context, the stu
Externí odkaz:
https://doaj.org/article/0a838e9bc7d2480e821ecdf4caa468dd
Autor:
Luigi Pasini, Michela Notarangelo, Alessandro Vagheggini, Marco Angelo Burgio, Lucio Crinò, Elisa Chiadini, Andrea Iamurri Prochowski, Angelo Delmonte, Paola Ulivi, Vito Giuseppe D'Agostino
Publikováno v:
Molecular Oncology, Vol 15, Iss 9, Pp 2423-2438 (2021)
The mutational status of the epidermal growth factor receptor (EGFR) guides the stratification of non‐small cell lung cancer (NSCLC) patients for treatment with tyrosine kinase inhibitors (TKIs). A liquid biopsy test on cell‐free DNA is recommend
Externí odkaz:
https://doaj.org/article/a104101c872849d4aae38dc98179fc13
Autor:
Paola Ulivi, Alessandro Passardi, Giorgia Marisi, Elisa Chiadini, Chiara Molinari, Matteo Canale, Luigi Pasini, Fabio Ferroni, Giovanni Luca Frassineti, Giulia Bartolini, Manlio Monti
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Liquid biopsy represents a valid strategy for tumor molecular characterization. It gives the opportunity to bypass tumor heterogeneity, to monitor tumor characteristics during the course of treatment, and to perform the analysis even when tumor tissu
Externí odkaz:
https://doaj.org/article/83b520a2d9594b96bbf750402e9697ce
Autor:
Luigi Pasini, Ivan Vannini, Paola Ulivi, Michela Tebaldi, Elisabetta Petracci, Francesco Fabbri, Franco Stella, Milena Urbini
Publikováno v:
Pharmaceutics, Vol 14, Iss 10, p 2029 (2022)
In recent years, circulating extracellular miRNAs have emerged as a useful tool for the molecular characterization and study of tumors’ biological functions. However, the high heterogeneity in sample processing, isolation of circulating fraction, R
Externí odkaz:
https://doaj.org/article/56b553b666174e1a8b82ab68f85633c4
Autor:
Michela Notarangelo, Chiara Zucal, Angelika Modelska, Isabella Pesce, Giorgina Scarduelli, Cristina Potrich, Lorenzo Lunelli, Cecilia Pederzolli, Paola Pavan, Giancarlo la Marca, Luigi Pasini, Paola Ulivi, Himisha Beltran, Francesca Demichelis, Alessandro Provenzani, Alessandro Quattrone, Vito G. D'Agostino
Publikováno v:
EBioMedicine, Vol 43, Iss , Pp 114-126 (2019)
Background: Extracellular vesicles (EVs) are secreted membranous particles intensively studied for their potential cargo of diagnostic markers. Efficient and cost-effective isolation methods need to be established for the reproducible and high-throug
Externí odkaz:
https://doaj.org/article/135b60c97b1549db8d2dcbf94f9312ce
Autor:
Matteo Canale, Kalliopi Andrikou, Ilaria Priano, Paola Cravero, Luigi Pasini, Milena Urbini, Angelo Delmonte, Lucio Crinò, Giuseppe Bronte, Paola Ulivi
Publikováno v:
Cancers, Vol 14, Iss 5, p 1143 (2022)
Non-Small-Cell Lung Cancer (NSCLC) is the primary cause of cancer-related death worldwide. Oncogene-addicted patients usually benefit from targeted therapy, but primary and acquired resistance mechanisms inevitably occur. Tumor protein 53 (TP53) gene
Externí odkaz:
https://doaj.org/article/dee7a34a2de14a4db430f1d1388b7886
Autor:
Annamaria Siggillino, Paola Ulivi, Luigi Pasini, Maria Sole Reda, Elisa Chiadini, Francesca Romana Tofanetti, Sara Baglivo, Giulio Metro, Lucio Crinó, Angelo Delmonte, Vincenzo Minotti, Fausto Roila, Vienna Ludovini
Publikováno v:
Diagnostics, Vol 10, Iss 12, p 1062 (2020)
Analysis of circulating cell-free tumor DNA (cftDNA) has emerged as a specific and sensitive blood-based approach to detect epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) patients. Still, there is some debate
Externí odkaz:
https://doaj.org/article/fd3f3ec7ec2447269d94d487d5b4507b
Autor:
Francesca Pirini, Luigi Pasini, Gianluca Tedaldi, Emanuela Scarpi, Giorgia Marisi, Chiara Molinari, Daniele Calistri, Alessandro Passardi, Paola Ulivi
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 10, p 3532 (2020)
Very few data are reported in the literature on the association between elevated microsatellite alterations at selected tetranucleotide repeats (EMAST) and prognosis in advanced colorectal cancer. Moreover, there is no information available in relati
Externí odkaz:
https://doaj.org/article/1532f169901f4ebcbe6f6d47da91179e
Autor:
Luigi Pasini, Paola Ulivi
Publikováno v:
Journal of Clinical Medicine, Vol 8, Iss 7, p 998 (2019)
The use of targeted agents and immunotherapy for the treatment of advanced non-small-cell lung cancer (NSCLC) has made it mandatory to characterize tumor tissue for patient selection. Moreover, the development of agents that are active against specif
Externí odkaz:
https://doaj.org/article/4882e0728ba240f4a56d47e05dbf72fa